Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Abdominal Cancer × Injections, Subcutaneous × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 2 Recurrent Metastatic Non-Squamous Non Small Cell Lung Cancer 1 Patient Preference 1 Inflammatory Breast Neoplasms 1 Abdominal Cancer 1

Interventions

Tea 1 Ketamine 1 Injections, Subcutaneous 1 Dexmedetomidine 1 Bupivacaine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02927379 2018-01-09

Effect of Wound Infiltration by Ketamine Versus Dexmedetomidine Added to Bupivacaine on Surgical Stress

Assiut University

Phase 3 Completed

Abdominal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡